These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8669667)

  • 1. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia].
    Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Rumberger E; Löscher W; Schulte am Esch J
    Anaesthesist; 1995 Aug; 44(8):538-44. PubMed ID: 7573901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
    Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
    J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene.
    Wappler F; Scholz J; von Richthofen V; Fiege M; Köchling A; Lambrecht W; Schulte am Esch J
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1312-8. PubMed ID: 9422298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Wappler F; Scholz J; Fiege M; Richter A; Steinfath M; Weisshorn R; Schulte am Esch J
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia.
    Gerbershagen MU; Wappler F; Fiege M; Kolodzie K; Weisshorn R; Szafarczyk W; Kudlik C; Schulte Am Esch J
    Br J Anaesth; 2003 Aug; 91(2):281-4. PubMed ID: 12878630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
    Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].
    Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Fiege M; Wappler F; Scholz J; Weisshorn R; von Richthofen V; Schulte am Esch J
    J Clin Anesth; 2000 Mar; 12(2):123-8. PubMed ID: 10818326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H; Bendixen D
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
    Hackl W; Winkler M; Mauritz W; Steinbereithner K
    Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine.
    Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte am Esch J
    Eur J Anaesthesiol; 2005 Apr; 22(4):283-8. PubMed ID: 15892406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.
    Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Schulte am Esch J
    Anesth Analg; 1996 Jun; 82(6):1230-6. PubMed ID: 8638796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
    Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
    J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron-induced muscular contractures in malignant hyperthermia-susceptible individuals.
    Johannsen S; Roewer N; Schuster F
    Anesth Analg; 2012 Oct; 115(4):925-8. PubMed ID: 22696611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal action potential responses to halothane in heart muscle isolated from malignant hyperthermia-susceptible pigs.
    Roewer N; Greim C; Rumberger E; Schulte am Esch J
    Anesthesiology; 1995 Apr; 82(4):947-53. PubMed ID: 7717567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effects of the phosphodiesterase-III inhibitor enoximone on malignant hyperthermia-susceptible swine.
    Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte Am Esch J
    Anesthesiology; 2003 Apr; 98(4):944-9. PubMed ID: 12657857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.